Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Filings indexed 1,262 across all filing types
Latest filing 2013-08-02 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2013-08-02 English
10-Q 6-30-2013
Interim / Quarterly Report Q2 2013
2013-08-02 English
BALCHEM CORPORATION 8-K 7-31-2013
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 31, 2013, reporting earnings for the second quarter ended June 30, 2013. It includes a press release as Exhibit 99.1 that reports financial results. The document is relatively short (2817 characters) and primarily serves as an announcement of earnings results rather than a full detailed financial report. The key phrase 'reported earnings for its second quarter' and the presence of a press release indicate this is an Earnings Release. It is not a full Interim/Quarterly Report (IR) because it lacks comprehensive financial statements or substantive financial data and analysis. Therefore, the correct classification is Earnings Release (ER).
2013-08-01 English
FORM 4
Director's Dealing
2013-07-22 English
FORM 4
Director's Dealing
2013-07-16 English
FORM 4
Director's Dealing
2013-07-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.